It showed that SW48‐FUBP1 with DVL1 knockdown and treatment with NSC668036 in SW48‐FUBP1 xenografts inhibited the tumor volume and tumorigenicity significantly (Fig. 6G,H; Table S5). This evidence concerns the gene DVL1 and neoplasm.